

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 9.90040349 |
| 2 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 7.61942142 |
| 3 | positive regulation of fatty acid oxidation (GO:0046321) | 6.55144778 |
| 4 | male sex determination (GO:0030238) | 5.40067185 |
| 5 | regulation of histone phosphorylation (GO:0033127) | 5.28849887 |
| 6 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 5.16429528 |
| 7 | protein import into peroxisome matrix (GO:0016558) | 5.14795080 |
| 8 | catecholamine transport (GO:0051937) | 5.01613012 |
| 9 | dopamine transport (GO:0015872) | 4.72137273 |
| 10 | platelet dense granule organization (GO:0060155) | 4.64685589 |
| 11 | regulation of smooth muscle cell differentiation (GO:0051150) | 4.64236208 |
| 12 | startle response (GO:0001964) | 4.58446584 |
| 13 | behavioral response to nicotine (GO:0035095) | 4.58177595 |
| 14 | meiotic chromosome segregation (GO:0045132) | 4.55125808 |
| 15 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.51023869 |
| 16 | gamma-aminobutyric acid transport (GO:0015812) | 4.34868092 |
| 17 | negative regulation of histone methylation (GO:0031061) | 4.34229732 |
| 18 | inositol metabolic process (GO:0006020) | 4.27807698 |
| 19 | bile acid and bile salt transport (GO:0015721) | 4.26718756 |
| 20 | oligosaccharide metabolic process (GO:0009311) | 4.24357468 |
| 21 | cellular response to pH (GO:0071467) | 4.15874134 |
| 22 | regulation of respiratory system process (GO:0044065) | 4.11338264 |
| 23 | positive regulation of CREB transcription factor activity (GO:0032793) | 4.07294662 |
| 24 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.05542718 |
| 25 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.00747687 |
| 26 | positive regulation of synapse assembly (GO:0051965) | 3.99697661 |
| 27 | inner mitochondrial membrane organization (GO:0007007) | 3.99304415 |
| 28 | suckling behavior (GO:0001967) | 3.94242103 |
| 29 | presynaptic membrane organization (GO:0097090) | 3.88951365 |
| 30 | left/right pattern formation (GO:0060972) | 3.88822264 |
| 31 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.86357087 |
| 32 | presynaptic membrane assembly (GO:0097105) | 3.79450321 |
| 33 | peroxisome fission (GO:0016559) | 3.71898912 |
| 34 | chaperone-mediated protein complex assembly (GO:0051131) | 3.62940423 |
| 35 | regulation of appetite (GO:0032098) | 3.61884786 |
| 36 | opioid receptor signaling pathway (GO:0038003) | 3.60470977 |
| 37 | protein localization to synapse (GO:0035418) | 3.57786811 |
| 38 | regulation of timing of cell differentiation (GO:0048505) | 3.45376738 |
| 39 | positive regulation of neurotransmitter transport (GO:0051590) | 3.43130840 |
| 40 | regulation of sequestering of triglyceride (GO:0010889) | 3.35580795 |
| 41 | regulation of synapse assembly (GO:0051963) | 3.32432229 |
| 42 | neuromuscular synaptic transmission (GO:0007274) | 3.30010011 |
| 43 | negative regulation of sodium ion transport (GO:0010766) | 3.23991448 |
| 44 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.23712153 |
| 45 | regulation of development, heterochronic (GO:0040034) | 3.23078203 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.22678984 |
| 47 | cysteine metabolic process (GO:0006534) | 3.19237389 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.17639670 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.14062863 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.14062863 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.14062863 |
| 52 | negative regulation of histone acetylation (GO:0035067) | 3.13382510 |
| 53 | positive regulation of lipid catabolic process (GO:0050996) | 3.12841249 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 3.07908579 |
| 55 | regulation of mitochondrial translation (GO:0070129) | 3.07773481 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.01420045 |
| 57 | histone-serine phosphorylation (GO:0035404) | 3.01201330 |
| 58 | regulation of respiratory gaseous exchange (GO:0043576) | 2.99200933 |
| 59 | aldehyde catabolic process (GO:0046185) | 2.98852428 |
| 60 | protein targeting to peroxisome (GO:0006625) | 2.97756086 |
| 61 | establishment of protein localization to peroxisome (GO:0072663) | 2.97756086 |
| 62 | protein localization to peroxisome (GO:0072662) | 2.97756086 |
| 63 | maturation of SSU-rRNA (GO:0030490) | 2.96648596 |
| 64 | negative regulation of fatty acid transport (GO:2000192) | 2.96563116 |
| 65 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.95094503 |
| 66 | sequestering of actin monomers (GO:0042989) | 2.91520685 |
| 67 | alanine transport (GO:0032328) | 2.89665951 |
| 68 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.83774528 |
| 69 | response to pheromone (GO:0019236) | 2.82723084 |
| 70 | protein complex biogenesis (GO:0070271) | 2.82508200 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 2.80135073 |
| 72 | ventricular system development (GO:0021591) | 2.78652886 |
| 73 | oxidative phosphorylation (GO:0006119) | 2.76754266 |
| 74 | intracellular protein transmembrane import (GO:0044743) | 2.76507110 |
| 75 | negative regulation of axon extension (GO:0030517) | 2.76163518 |
| 76 | regulation of fatty acid oxidation (GO:0046320) | 2.72915092 |
| 77 | fear response (GO:0042596) | 2.72127132 |
| 78 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.72111343 |
| 79 | monoamine transport (GO:0015844) | 2.71685649 |
| 80 | spinal cord motor neuron differentiation (GO:0021522) | 2.70346849 |
| 81 | lung secretory cell differentiation (GO:0061140) | 2.68140927 |
| 82 | behavioral fear response (GO:0001662) | 2.65909867 |
| 83 | behavioral defense response (GO:0002209) | 2.65909867 |
| 84 | peroxisomal transport (GO:0043574) | 2.65628593 |
| 85 | sex determination (GO:0007530) | 2.65208234 |
| 86 | cardiolipin metabolic process (GO:0032048) | 2.64940780 |
| 87 | anterograde synaptic vesicle transport (GO:0048490) | 2.64902866 |
| 88 | peripheral nervous system axon ensheathment (GO:0032292) | 2.64617855 |
| 89 | myelination in peripheral nervous system (GO:0022011) | 2.64617855 |
| 90 | multicellular organism reproduction (GO:0032504) | 2.63763668 |
| 91 | neuronal stem cell maintenance (GO:0097150) | 2.62654184 |
| 92 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.61336610 |
| 93 | regulation of synapse organization (GO:0050807) | 2.61260401 |
| 94 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.61113956 |
| 95 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.60416496 |
| 96 | intracellular protein transmembrane transport (GO:0065002) | 2.59332384 |
| 97 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.55826547 |
| 98 | regulation of axon guidance (GO:1902667) | 2.55464388 |
| 99 | N-acetylglucosamine metabolic process (GO:0006044) | 2.54637215 |
| 100 | oligosaccharide biosynthetic process (GO:0009312) | 15.4954433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AR_21572438_ChIP-Seq_LNCaP_Human | 5.25440798 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.99036136 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.62237040 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.43003904 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36287439 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.01218017 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93379136 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.75634006 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19378801 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18548187 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.93602460 |
| 12 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.91872110 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91819835 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90253514 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87649090 |
| 16 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.86580955 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82125668 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79856527 |
| 19 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.77995220 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70606116 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69250878 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68777858 |
| 23 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.67762850 |
| 24 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.67762850 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66379930 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64664385 |
| 27 | AR_25329375_ChIP-Seq_VCAP_Human | 1.63268423 |
| 28 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.62010062 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60585104 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59687654 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56461969 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55319492 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.55259874 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52257403 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50387722 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45815680 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.44115007 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41500974 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40886668 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.40142434 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38453325 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38238165 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38238165 |
| 44 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35558104 |
| 45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35028903 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34547550 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.32581787 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31552103 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31195197 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30832855 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30520499 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29709061 |
| 53 | NCOR_22424771_ChIP-Seq_293T_Human | 1.29384672 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29054017 |
| 55 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28120714 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25848567 |
| 57 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.25725653 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23665767 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23407566 |
| 60 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.22273331 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21365952 |
| 62 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21134843 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20182471 |
| 64 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19073510 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18149374 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17958128 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13488530 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13341332 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12757781 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12669150 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12622405 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11000040 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10584016 |
| 74 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.09504111 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09138376 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08836147 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08729693 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08520464 |
| 79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08141879 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08019131 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06915098 |
| 82 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.06330480 |
| 83 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05417124 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05146749 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05146749 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03290511 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02514946 |
| 88 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02246471 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99760861 |
| 90 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98941498 |
| 91 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97726463 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96338835 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96338835 |
| 94 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.95576850 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94634994 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93669013 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92389073 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90216512 |
| 99 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.90175955 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88161068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 4.93008604 |
| 2 | MP0000566_synostosis | 3.62547517 |
| 3 | MP0005423_abnormal_somatic_nervous | 3.03730001 |
| 4 | MP0003011_delayed_dark_adaptation | 2.93175653 |
| 5 | MP0004885_abnormal_endolymph | 2.71274930 |
| 6 | MP0004130_abnormal_muscle_cell | 2.63313863 |
| 7 | MP0008961_abnormal_basal_metabolism | 2.47871198 |
| 8 | MP0004133_heterotaxia | 2.46820884 |
| 9 | MP0001529_abnormal_vocalization | 2.36442641 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.32938298 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.17026372 |
| 12 | MP0003880_abnormal_central_pattern | 2.15546634 |
| 13 | MP0002733_abnormal_thermal_nociception | 2.07786369 |
| 14 | MP0003646_muscle_fatigue | 2.04995695 |
| 15 | MP0000569_abnormal_digit_pigmentation | 1.99590739 |
| 16 | MP0001502_abnormal_circadian_rhythm | 1.97746943 |
| 17 | MP0005386_behavior/neurological_phenoty | 1.96068728 |
| 18 | MP0004924_abnormal_behavior | 1.96068728 |
| 19 | MP0002735_abnormal_chemical_nociception | 1.95637378 |
| 20 | MP0005360_urolithiasis | 1.94739372 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.92783124 |
| 22 | MP0004147_increased_porphyrin_level | 1.85010348 |
| 23 | MP0001486_abnormal_startle_reflex | 1.83726562 |
| 24 | MP0001970_abnormal_pain_threshold | 1.82291378 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76746165 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.75646955 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.74181118 |
| 28 | MP0009745_abnormal_behavioral_response | 1.71006585 |
| 29 | MP0005448_abnormal_energy_balance | 1.69215333 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.66591031 |
| 31 | MP0004142_abnormal_muscle_tone | 1.65388115 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.64803281 |
| 33 | MP0004742_abnormal_vestibular_system | 1.59511540 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.56094104 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.52677948 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.52134791 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.49959571 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.49201535 |
| 39 | MP0004043_abnormal_pH_regulation | 1.47690779 |
| 40 | MP0002938_white_spotting | 1.45674673 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.45577167 |
| 42 | MP0009046_muscle_twitch | 1.43936139 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.43122524 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.42229284 |
| 45 | MP0000778_abnormal_nervous_system | 1.42077125 |
| 46 | MP0003136_yellow_coat_color | 1.37854188 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.36146232 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.31500532 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.30696841 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.28774117 |
| 51 | MP0000534_abnormal_ureter_morphology | 1.26109012 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.24643752 |
| 53 | MP0001963_abnormal_hearing_physiology | 1.23792604 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.21869760 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.21198286 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.21065779 |
| 57 | MP0003137_abnormal_impulse_conducting | 1.18906226 |
| 58 | MP0002069_abnormal_eating/drinking_beha | 1.18839343 |
| 59 | MP0005253_abnormal_eye_physiology | 1.13391923 |
| 60 | MP0008872_abnormal_physiological_respon | 1.10331565 |
| 61 | MP0001664_abnormal_digestion | 1.06044120 |
| 62 | MP0000371_diluted_coat_color | 1.05639684 |
| 63 | MP0008995_early_reproductive_senescence | 1.04696590 |
| 64 | MP0005171_absent_coat_pigmentation | 1.02258001 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.01755496 |
| 66 | MP0002064_seizures | 1.01574978 |
| 67 | MP0002736_abnormal_nociception_after | 1.01239843 |
| 68 | MP0000372_irregular_coat_pigmentation | 0.99954116 |
| 69 | MP0000026_abnormal_inner_ear | 0.97068336 |
| 70 | MP0004215_abnormal_myocardial_fiber | 0.95966039 |
| 71 | MP0003937_abnormal_limbs/digits/tail_de | 0.94859601 |
| 72 | MP0003861_abnormal_nervous_system | 0.94192422 |
| 73 | MP0001958_emphysema | 0.92649168 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.92295827 |
| 75 | MP0001929_abnormal_gametogenesis | 0.92033601 |
| 76 | MP0005595_abnormal_vascular_smooth | 0.88448328 |
| 77 | MP0002067_abnormal_sensory_capabilities | 0.88111527 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 0.87686678 |
| 79 | MP0002272_abnormal_nervous_system | 0.87120615 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.85988474 |
| 81 | MP0005310_abnormal_salivary_gland | 0.84398520 |
| 82 | MP0005187_abnormal_penis_morphology | 0.82526710 |
| 83 | MP0002971_abnormal_brown_adipose | 0.79868283 |
| 84 | MP0002210_abnormal_sex_determination | 0.78854263 |
| 85 | MP0001944_abnormal_pancreas_morphology | 0.78836023 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.78306850 |
| 87 | MP0005195_abnormal_posterior_eye | 0.78180444 |
| 88 | MP0002152_abnormal_brain_morphology | 0.78156487 |
| 89 | MP0001873_stomach_inflammation | 0.77549204 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.76546341 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.76174047 |
| 92 | MP0002089_abnormal_postnatal_growth/wei | 0.76084618 |
| 93 | MP0003698_abnormal_male_reproductive | 0.76077769 |
| 94 | MP0003195_calcinosis | 0.75687136 |
| 95 | MP0001663_abnormal_digestive_system | 0.74804680 |
| 96 | MP0000653_abnormal_sex_gland | 0.74356590 |
| 97 | MP0002108_abnormal_muscle_morphology | 0.72708561 |
| 98 | MP0002282_abnormal_trachea_morphology | 0.72707330 |
| 99 | MP0002882_abnormal_neuron_morphology | 0.72150096 |
| 100 | MP0009115_abnormal_fat_cell | 0.71015668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.73242767 |
| 2 | Turricephaly (HP:0000262) | 5.43628309 |
| 3 | Protruding tongue (HP:0010808) | 5.11624154 |
| 4 | Renal cortical cysts (HP:0000803) | 4.43814668 |
| 5 | Bell-shaped thorax (HP:0001591) | 4.33660418 |
| 6 | Brushfield spots (HP:0001088) | 4.26584724 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 4.13250695 |
| 8 | Large for gestational age (HP:0001520) | 3.88263725 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.74054248 |
| 10 | Global brain atrophy (HP:0002283) | 3.71110211 |
| 11 | Hyperventilation (HP:0002883) | 3.60246836 |
| 12 | Flat occiput (HP:0005469) | 3.58361230 |
| 13 | Abnormality of the renal cortex (HP:0011035) | 3.42347477 |
| 14 | Type II lissencephaly (HP:0007260) | 3.40176346 |
| 15 | Broad metatarsal (HP:0001783) | 3.38807602 |
| 16 | Infantile muscular hypotonia (HP:0008947) | 3.28433902 |
| 17 | Patellar aplasia (HP:0006443) | 3.00635212 |
| 18 | Hypoplastic ischia (HP:0003175) | 2.96782171 |
| 19 | Focal motor seizures (HP:0011153) | 2.94837146 |
| 20 | Clumsiness (HP:0002312) | 2.90676299 |
| 21 | Tubulointerstitial nephritis (HP:0001970) | 2.89288365 |
| 22 | Breast hypoplasia (HP:0003187) | 2.81842253 |
| 23 | Intellectual disability, progressive (HP:0006887) | 2.80928643 |
| 24 | Redundant skin (HP:0001582) | 2.80171427 |
| 25 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.78490712 |
| 26 | Spastic tetraparesis (HP:0001285) | 2.74599548 |
| 27 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.72849928 |
| 28 | Female pseudohermaphroditism (HP:0010458) | 2.67821604 |
| 29 | Long nose (HP:0003189) | 2.63928692 |
| 30 | Decreased central vision (HP:0007663) | 2.63668520 |
| 31 | Lissencephaly (HP:0001339) | 2.58746020 |
| 32 | Increased IgE level (HP:0003212) | 2.56784045 |
| 33 | Chronic sinusitis (HP:0011109) | 2.54904879 |
| 34 | Pendular nystagmus (HP:0012043) | 2.54457717 |
| 35 | Breech presentation (HP:0001623) | 2.53785846 |
| 36 | Fair hair (HP:0002286) | 2.52659494 |
| 37 | Polymicrogyria (HP:0002126) | 2.50912395 |
| 38 | Partial duplication of the phalanx of hand (HP:0009999) | 2.50140741 |
| 39 | Abnormality of the ischium (HP:0003174) | 2.47490166 |
| 40 | Retinal atrophy (HP:0001105) | 2.46928053 |
| 41 | Posterior embryotoxon (HP:0000627) | 2.46770888 |
| 42 | Congenital, generalized hypertrichosis (HP:0004540) | 2.44519722 |
| 43 | Cerebellar dysplasia (HP:0007033) | 2.42874316 |
| 44 | Prominent supraorbital ridges (HP:0000336) | 2.38596359 |
| 45 | Abnormality of the line of Schwalbe (HP:0008048) | 2.33113551 |
| 46 | Furrowed tongue (HP:0000221) | 2.26515549 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25597930 |
| 48 | Retinal dysplasia (HP:0007973) | 2.24655286 |
| 49 | Aplasia involving bones of the extremities (HP:0009825) | 2.20991609 |
| 50 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20991609 |
| 51 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20991609 |
| 52 | Genetic anticipation (HP:0003743) | 2.16409824 |
| 53 | Clitoromegaly (HP:0000057) | 2.11831491 |
| 54 | Ovoid vertebral bodies (HP:0003300) | 2.11224698 |
| 55 | Broad-based gait (HP:0002136) | 2.06915108 |
| 56 | Abnormality of the parietal bone (HP:0002696) | 2.06852769 |
| 57 | Depressed nasal tip (HP:0000437) | 2.06779010 |
| 58 | Molar tooth sign on MRI (HP:0002419) | 2.05580517 |
| 59 | Abnormality of midbrain morphology (HP:0002418) | 2.05580517 |
| 60 | Metabolic alkalosis (HP:0200114) | 2.02529839 |
| 61 | Generalized hypopigmentation of hair (HP:0011358) | 2.01960544 |
| 62 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.01202984 |
| 63 | Hyperglycinuria (HP:0003108) | 2.01104732 |
| 64 | Visual hallucinations (HP:0002367) | 2.00927696 |
| 65 | Thoracic kyphosis (HP:0002942) | 2.00761627 |
| 66 | Absent/shortened dynein arms (HP:0200106) | 1.99775731 |
| 67 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99775731 |
| 68 | Thyroid-stimulating hormone excess (HP:0002925) | 1.98442874 |
| 69 | Intellectual disability, severe (HP:0010864) | 1.98057948 |
| 70 | Hyperaldosteronism (HP:0000859) | 1.95176278 |
| 71 | Optic disc pallor (HP:0000543) | 1.94647858 |
| 72 | Epiphyseal stippling (HP:0010655) | 1.92659254 |
| 73 | Broad toe (HP:0001837) | 1.91916805 |
| 74 | Widely patent fontanelles and sutures (HP:0004492) | 1.89611686 |
| 75 | Abnormality of the sella turcica (HP:0002679) | 1.88834549 |
| 76 | Pancreatic fibrosis (HP:0100732) | 1.88492469 |
| 77 | True hermaphroditism (HP:0010459) | 1.88356991 |
| 78 | Broad hallux (HP:0010055) | 1.88177957 |
| 79 | Recurrent corneal erosions (HP:0000495) | 1.84652529 |
| 80 | Tubulointerstitial abnormality (HP:0001969) | 1.81146624 |
| 81 | Coronal craniosynostosis (HP:0004440) | 1.80799992 |
| 82 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80661382 |
| 83 | Adrenal hypoplasia (HP:0000835) | 1.79022029 |
| 84 | Hyperalaninemia (HP:0003348) | 1.79007330 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79007330 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 1.79007330 |
| 87 | Absent septum pellucidum (HP:0001331) | 1.76237609 |
| 88 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76124445 |
| 89 | Underdeveloped supraorbital ridges (HP:0009891) | 1.75906923 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.75759147 |
| 91 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.75401982 |
| 92 | Prolonged QT interval (HP:0001657) | 1.74967374 |
| 93 | Short hallux (HP:0010109) | 1.73935194 |
| 94 | Drooling (HP:0002307) | 1.72620092 |
| 95 | Tented upper lip vermilion (HP:0010804) | 1.71727197 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 1.71300097 |
| 97 | Hydroxyprolinuria (HP:0003080) | 1.71300097 |
| 98 | Hyperkalemia (HP:0002153) | 1.69817345 |
| 99 | Acute encephalopathy (HP:0006846) | 1.68175428 |
| 100 | Abnormality of the septum pellucidum (HP:0007375) | 1.64838875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 3.12735606 |
| 2 | NEK9 | 2.92528847 |
| 3 | MUSK | 2.87146018 |
| 4 | NTRK1 | 2.40372809 |
| 5 | INSRR | 12.2073208 |
| 6 | TRIB3 | 1.84177444 |
| 7 | MET | 1.84079587 |
| 8 | CLK1 | 1.77029125 |
| 9 | BRSK2 | 1.73829639 |
| 10 | DAPK2 | 1.72015475 |
| 11 | LATS1 | 1.63116699 |
| 12 | PNCK | 1.62747524 |
| 13 | MAPK13 | 1.48882359 |
| 14 | ADRBK1 | 1.43664802 |
| 15 | NTRK2 | 1.38931154 |
| 16 | MAP3K2 | 1.37596699 |
| 17 | ERBB3 | 1.31005830 |
| 18 | MAP2K2 | 1.20185149 |
| 19 | FGR | 1.10798596 |
| 20 | PTK2B | 1.05511855 |
| 21 | STK38 | 1.05379704 |
| 22 | PIK3CA | 1.02574286 |
| 23 | CAMK1D | 1.01102714 |
| 24 | ADRBK2 | 0.97714475 |
| 25 | STK38L | 0.97184773 |
| 26 | RET | 0.96376168 |
| 27 | EPHB1 | 0.95387686 |
| 28 | PDGFRB | 0.91557431 |
| 29 | OXSR1 | 0.91505831 |
| 30 | MAPK15 | 0.89951577 |
| 31 | STK39 | 0.89704969 |
| 32 | TLK1 | 0.87684607 |
| 33 | FRK | 0.85702645 |
| 34 | BMX | 0.85640165 |
| 35 | IRAK4 | 0.85493657 |
| 36 | WNK4 | 0.83971320 |
| 37 | CAMKK1 | 0.82022871 |
| 38 | IRAK2 | 0.80118141 |
| 39 | VRK2 | 0.80108023 |
| 40 | TAOK3 | 0.79630737 |
| 41 | MAP3K11 | 0.77915361 |
| 42 | WEE1 | 0.73061229 |
| 43 | NUAK1 | 0.72236104 |
| 44 | GRK5 | 0.71779549 |
| 45 | TNK2 | 0.70609783 |
| 46 | CSF1R | 0.69866086 |
| 47 | PINK1 | 0.69609824 |
| 48 | ERBB2 | 0.69010028 |
| 49 | BMPR1B | 0.66637978 |
| 50 | MAPK11 | 0.66129959 |
| 51 | ACVR1B | 0.66019643 |
| 52 | GRK1 | 0.64660491 |
| 53 | TGFBR1 | 0.63096665 |
| 54 | MKNK2 | 0.62949876 |
| 55 | MARK1 | 0.61159872 |
| 56 | CAMKK2 | 0.61111886 |
| 57 | CCNB1 | 0.58958623 |
| 58 | PLK4 | 0.58586509 |
| 59 | ICK | 0.58127735 |
| 60 | VRK1 | 0.56880020 |
| 61 | BRSK1 | 0.56701884 |
| 62 | KSR2 | 0.54791325 |
| 63 | CASK | 0.54529160 |
| 64 | MAP3K10 | 0.52893038 |
| 65 | HIPK2 | 0.52007107 |
| 66 | WNK3 | 0.51779648 |
| 67 | RPS6KA6 | 0.51052201 |
| 68 | RPS6KA5 | 0.47137408 |
| 69 | CAMK1G | 0.45258648 |
| 70 | TSSK6 | 0.44562888 |
| 71 | LATS2 | 0.43928500 |
| 72 | PTK6 | 0.40786204 |
| 73 | IGF1R | 0.39255755 |
| 74 | STK11 | 0.36199229 |
| 75 | MAP3K12 | 0.35637549 |
| 76 | MAP2K1 | 0.35126335 |
| 77 | PRKAA2 | 0.31992876 |
| 78 | NLK | 0.30974063 |
| 79 | ILK | 0.27509230 |
| 80 | DYRK1A | 0.26336027 |
| 81 | CAMK2A | 0.26031775 |
| 82 | MAPKAPK5 | 0.25948024 |
| 83 | GRK6 | 0.24623286 |
| 84 | PRKCG | 0.24483163 |
| 85 | RIPK4 | 0.22852370 |
| 86 | PBK | 0.21369618 |
| 87 | PRKACA | 0.20917696 |
| 88 | BRAF | 0.20806927 |
| 89 | FLT3 | 0.19760131 |
| 90 | MKNK1 | 0.19137884 |
| 91 | ZAP70 | 0.18348041 |
| 92 | MELK | 0.17904323 |
| 93 | PASK | 0.17869267 |
| 94 | EPHA4 | 0.17798176 |
| 95 | LCK | 0.15815011 |
| 96 | PRKACG | 0.14572301 |
| 97 | CAMK4 | 0.14490092 |
| 98 | PRKCE | 0.14307027 |
| 99 | PLK1 | 0.12158298 |
| 100 | ROCK1 | 0.11896058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 8.36453869 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.94374527 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.05709119 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.75020490 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.71825278 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.23502857 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20433752 |
| 8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.09620819 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.00243412 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.92163915 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 1.89828149 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85497894 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76964490 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.74118852 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64150730 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61328774 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.54933159 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.53339983 |
| 19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.52026918 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.49440218 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.46758371 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36282026 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35618641 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34411586 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.31574218 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27254587 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18835677 |
| 28 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18809117 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11605126 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07204053 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.05171121 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04793054 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87908587 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 0.87580267 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86560262 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84485316 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83882554 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 0.82715972 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76851463 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75779904 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74999893 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73890177 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73033033 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70969881 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 0.68571430 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63498446 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62254975 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61424365 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60945595 |
| 50 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60834633 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.58903732 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58444107 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55020406 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55007069 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53746285 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51949976 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51896541 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51078520 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50698632 |
| 60 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50391065 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49762705 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46672973 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.45444010 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44237109 |
| 65 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41081310 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40821853 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40321752 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38065307 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37535735 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35170851 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35035313 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34825734 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34772466 |
| 74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34769355 |
| 75 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33749440 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33714832 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32876416 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.32673531 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31529778 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.30183999 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30034814 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29836519 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29633745 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29017182 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28023794 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27594247 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.27574518 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27364322 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27087897 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25611072 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24052060 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23623148 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.22669878 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22508880 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21935250 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21161285 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.20654092 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.20031618 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.19145105 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18698692 |

